CULLINAN THERAPEUTICS INC. - COMMON STOCK
9.8500
12-February-25 15:53:12
15 minutes delayed
Stocks
+0.0400
+0.41%
Today's range
9.5000 - 9.9500
ISIN
N/A
Source
NASDAQ
-
Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
13 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference
22 Nov 2021 12:37:10 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
09 Nov 2021 06:45:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer
18 Oct 2021 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
08 Sep 2021 16:01:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
10 Aug 2021 06:30:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in the 41st Annual Canaccord Genuity Growth Conference
05 Aug 2021 16:05:00 By Nasdaq GlobeNewswire
-
29 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
07 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
04 Jun 2021 09:00:01 By Nasdaq GlobeNewswire
-
Cullinan Oncology Announces Management Transition
21 May 2021 08:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Provide CLN-081 Clinical Update at ASCO 2021
19 May 2021 17:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports First Quarter 2021 Financial Results
14 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference
07 Apr 2021 10:08:07 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Full Year 2020 Financial Results and Business Highlights
30 Mar 2021 06:15:00 By Nasdaq GlobeNewswire